Ayana, Sisay
Aynalem, Melak
Adane, Tiruneh
Shiferaw, Elias
Article History
Received: 23 October 2024
Accepted: 12 May 2025
First Online: 15 May 2025
Declarations
:
: The authors declare no competing interests.
: The study was conducted after reviewed and approved by the ethical review committee of the School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar with (Reference No. SBMLS/514). Moreover, letter of support was submitted to the UoG-CSH and FHCSH. Before starting the actual data collection, permission was obtained from both Hospitals Chief Executive Officer. Additionally, after explaining the purpose, benefits, and the possible risks of the study, written informed consent from the age of 18 and above and/or assent from those less than 18 years old study participants along with written informed consent from their respective parents/caregiver/guardians was obtained. And also, written informed consent from illiterate study participants was obtained from their respective parents/guardians. All laboratory results were kept confidential. Since those were stored in a file using codes without study participant’s name. Apparently healthy participants, those positive for parasites, abnormal coagulation profiles, and platelet count were linked to the hospitals for appropriate treatment and management. All methods were carried out in accordance with relevant guidelines and regulations.